IMHO it doesn't matter as neoHERIZON seeks to evaluate the effectiveness of HER-Vaxx + chemo WITH OR WITHOUT Bavencio.
If they give IMU a dodgy patch of the stuff then the results will reflect badly on their products, if it turns out that HER-Vaxx + chemo works better without Bavencio, not to mention their QA procedures.
GLTA
Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer, page-186
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
-0.001(0.85%) |
Mkt cap ! $440.9M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.2¢ | 5.8¢ | $1.284M | 21.33M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 1363702 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 318064 | 21 |
View Market Depth
| Last trade - 11.55am 15/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |